Linamar reports a 17.2% earnings surge

Linamar reports a 17.2% earnings surge

We continue to believe there’s room for most investors to hold aggressive stocks, which typically are more leveraged (with more debt) and volatile than conservative stocks.

 Still, to cut your risk, you should limit aggressive stocks to no more than 20% of your total portfolio. We… Read More

AbbVie’s new drugs will spur your dividend

Sales of drug maker AbbVie’s main product, Humira, have suffered lately due to competition from generic versions. However, recent acquisitions have strengthened the pharmaceutical giant’s development portfolio; that bodes well for more dividend increases.
ABBVIE INC. $176 is a buy. The company (New York symbol ABBV; High-Growth Dividend… Read More